Cell Cure Gets Backing From Zhongshan Oncologist Group For Advanced Cancer Therapy

According to 36KR, Zhongshan Oncologist Group was founded in 2018, it's the first doctor group in China that has tumor expert from Macau and Hong Kong. Right now, the group has more than 2000 doctors across China. The service mode of Zhongshan Oncologist Group is to examine the advanced technologies and products from Hong Kong, Macao and foreign countries by the doctors' group. After that, the group would work with Chinese mainland hospitals to provide these services for Chinese patients.

In recent days, Zhongshan Oncologist Group invested in Cell Cure, which is a treatment center that provides SIRT therapy, biological therapy, immunotherapy, targeted therapy and other therapy. Selective Internal Radiation Therapy is a special radiotherapy method. SIRT treatment delivers high doses of radioactive particles to specific locations in the body, selectively killing tumor cells and causing minimal damage to normal tissues and organs.

At present, SIRT is available in 40 countries around the world. However, this product is still unavailable in mainland China, that's why this investment is vital for Chinese cancer patients, since China has countless new cancer patients each year and really needs new methods to improve the survival rate of cancer patients.  

A doctor group with more than 2000 doctors across mainland China, Hong Kong and Macau that provide new treatment for Chinese cancer patients.